• 10 Hits
  • Search Condition : Filter (MeSH = Receptor, ErbB-2 / antagonists & inhibitors)
Species Resource Title
Human and Animal Cells NUGC-4(RCB1939) Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer.
Human and Animal Cells SH-10-TC(RCB1940) Radioimmunotherapy with an 211 At-labeled anti-tissue factor antibody protected by sodium ascorbate.
Human and Animal Cells iPS-MEF-Ng-20D-17(APS0001) , PK-8(RCB2700) The significance of ErbB2/3 in the conversion of induced pluripotent stem cells into cancer stem cells.
Human and Animal Cells CW-2(RCB0778) Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity.
Human and Animal Cells PC-9(RCB4455) Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14-mutant Non-small Cell Lung Cancer.
DNA material pCALNL5 (RDB01862). Overexpression of HER2 in the pancreas promotes development of intraductal papillary mucinous neoplasms in mice.
Human and Animal Cells MKN7(RCB0999) Locoregional therapy with α-emitting trastuzumab against peritoneal metastasis of human epidermal growth factor receptor 2-positive gastric cancer in mice.
Human and Animal Cells YSCCC(RCB1549) , TGBC1TKB(RCB1129) , TGBC2TKB(RCB1130) , TGBC14TKB(RCB1186) Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.
Human and Animal Cells MKN45(RCB1001) The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer.
Human and Animal Cells HiPS-RIKEN-2F(HPS0014) A Paracrine Mechanism Accelerating Expansion of Human Induced Pluripotent Stem Cell-Derived Hepatic Progenitor-Like Cells.